Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
During this study blood was collected every one to two weeks for follow-up measurements
(Honestly, I usually try to change the subject when it comes up.) So I find it a little odd that this next story which starts with the upsetting news that scientists estimate theres roughly a 50-50 chance the world will face another global pandemic in the next 25 years is actually rather empowering
Jorsal A, Kistorp C, Holmager P, Tougaard RS, Nielsen R, Hanselmann A, et al
Colavitti, R
Active, not recruiting Influenza Combination Product: CD388 Injection Combination Product: Placebo Efficacy and Safety of NVX-CoV2705 (COVID-19) This is a Phase 4, post-market US study, evaluating the efficacy and safety of a single dose of the NVX-CoV2705 Omicron JN.1 COVID-19 vaccine
